Cite
HARVARD Citation
Abidin, A. et al. (2021). Infliximab switching from reference product to biosimilar: a review of evidence regarding the clinical efficacy, safety profile and immunogenicity. Journal of pharmacy practice and research. pp. 358-373. [Online].